Results

Total Results: 428 records

Showing results for "grade d cancer".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
    November 18, 2024 - This includes cancer and malabsorption syndromes. … and/or Canadian consumers • Countries rated very high on the Human Development Index (HDI)d at … The strength of evidence will be assigned an overall grade of high, moderate, low, or insufficient ( … https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-107/subpart-D/section- 107.100. … Advanced Dietary Analysis and Modeling: A Deep Dive into the National Cancer Institute Method.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-block-protocol.pdf
    November 18, 2023 - D. … Xiao D, Sun Y, Gong F, Yin Y, Wang Y. … GRADE guidelines: 11. … Atkins D, Chang SM, Gartlehner G, et al. … Data Abstraction and Data Management D.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
    February 24, 2016 - A Technical Brief does not synthesize data on outcomes or grade evidence. … d.   … d.   What are important areas of uncertainty for MAT? e.   … Boudreau D, Von Korff M, Rutter CM, et al. … Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf.
  4. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
    August 19, 2024 - This includes cancer and malabsorption syndromes. … The strength of evidence will be assigned an overall grade of high, moderate, low, or insufficient ( … PMID: 19711246. 12. 1 D. 1,000 Days. https://thousanddays.org/about/. . … https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-107/subpart-D/section- 107.100. … Advanced Dietary Analysis and Modeling: A Deep Dive into the National Cancer Institute Method.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
    November 07, 2019 - period of time, and it is the appropriate choice for treating their condition (e.g., certain types of cancer … Systematic Review: Grading the Strength of Evidence For KQ 3, we will grade the strength of evidence … (SOE) based on the guidance established for the EPC Program.42 Developed to grade the overall strength … Definitions of the grades of overall strength of evidence42 Grade Definition High High confidence … Atkins D, Chang SM, Gartlehner G, et al.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - disease, hypertension, type-2 diabetes, obesity, chronic kidney disease, bone disease, hyperlipidemia, cancer … support), criminal history, or clinical, personal and family medical and mental history factors (e.g., cancer … including but not limited to infections such as hepatitis C, tuberculosis, and opportunistic infections, cancers … Examples of co-occurring diseases of interest include cancer, infections (including hepatitis C, human … Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-cost-measures_disposition-comments.pdf
    March 05, 2015 - The consumers who really use websites are those with acute cancer, serious and severe surgical procedures … d. … d. … d. … d. Thank you for this comment.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - d. … eprosartan versus enalapril over 12 weeks, reported one death in each group, a 95-year-old patient with cancer … Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. … Ruff D, Gazdick LP, Berman R, et al. … Black HR, Graff A, Shute D, et al.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
    April 01, 2022 - Kanaka D. Shetty, M.D., M.S. … C-1 Appendix D. … D-1 Appendix E. … 1 Appendix D. … Therapeutic ultrasound for knee osteoarthritis: A systematic review and meta-analysis with grade quality
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
    December 31, 2022 - confounding, and strength of association (see Appendix B for more details).22 We used the same domains to grade … Lumley S, O’Donnell D, Stoesser N, et al. … Hansen CH, Michlmayr D, Gubbels SM, et al. … Abo-Leyah H, Gallant S, Cassidy D, et al. … Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
    April 01, 2013 - of complications from chronic liver disease, including cirrhosis, liver failure, and hepatocellular cancer … health complications associated with HCV infection such as cirrhosis, hepatic decompensation, and liver cancer … evaluated the association between achieving an SVR and reductions in mortality, liver failure, and cancer … Adverse events, including serious adverse events and grade 3-4 laboratory abnormalities. … 1 Appendix D.
  12. effectivehealthcare.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
    April 16, 2020 - In particular, we would appreciate if you would add evidence profiles in the style of GRADE summarizing … The most detailed SOE tables are in Appendix G; these may most closely resemble GRADE profile tables … Thomas E, Cavallaro AR, Mani D, et al. … Bull Cancer. 2019 May;106(5):436-46. doi: 10.1016/j.bulcan.2019.03.005. PMID: 31005246. … D., & Beehler, G. P. (2010).
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
    December 01, 2017 - d. … d. … Dobbins M, Hanna SE, Ciliska D, et al. … Norris SL, Atkins D, Bruening W, et al. … Using NCCN clinical practice guidelines in oncology to measure the quality of colorectal cancer care
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
    April 01, 2014 - this report.2 In 2009, more than 250,000 colorectal surgeries were recorded,3 most commonly for cancer … Common indications for surgery were colorectal cancer and diverticular disease. … The most common indications for surgery were colorectal cancer and diverticular disease. … W he n re po rte d, st ud y- sp ec ifi c re su lts d id n ot le ad to d efi ni tiv … leakage, wound infection, and peritonitis for patients undergoing elective surgery for colorectal cancer
  15. Insomnia Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
    December 01, 2015 - reported harms if they (1) included adults with chronic insomnia without other major diagnoses, such as cancer … Both zolpidem and temazepam were associated with incident cancers. … studies suggested that hypnotic use is correlated with dementia, fractures, major injuries, and possibly cancer … Revicki D, Hays RD, Cella D, et al. … Possibility that certain hypnotics might cause cancer in skin.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - Marra A, Generali D, Zagami P, et al. … Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies … Blood Cancer Journal. 2021;11(9):151. doi: http://dx.doi.org/10.1038/s41408-021-00546-9. … Michlmayr D, Hansen CH, Gubbels SM, et al. … Abo-Leyah H, Gallant S, Cassidy D, et al.
  17. effectivehealthcare.ahrq.gov/sites/default/files/noninvasive-nonpharm-pain-summary.pdf
    April 01, 2020 - guidelines from the CDC7 in the United States and the Canadian Guidelines for Opioid Use in Chronic Non-Cancer … Dowell D, Haegerich TM, Chou R. … The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain. … Foster NE, Anema JR, Cherkin D, et al. … Deyo RA, Dworkin SF, Amtmann D, et al.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - arrhythmia) • Exclude populations chosen for having a non- CVD or nondiabetes-related disease (e.g., cancer … Across RCTs, EPA+DHA doses ranged from 0.34 to 6 g/d (median 0.866 g/d). … 1.8 vs. 0.9 or 0.45 g/d; 3.4 vs. 1.7 g/d). … DHA 3.6 g/d; EPA+DHA 3.4 and 1.7 g/d vs. … One trial compared 2.0 g/d SDA and 1.9 g/d EPA+DHA+DPA in healthy people.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
    June 12, 2012 - "Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 Tumors. … Budoff MJ, Dowe D, Jollis JG, et al. … Budoff MJ, Dowe D, Jollis JG, et al. … Exercise duration is also not well defined; d. … I was not aware of the excess cancer risk, and wanted to know what cancers these are (i.e., in the
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
    March 01, 2012 - The text was revised accordingly to specify that ONJ was reported in patients being treated for malignancies … Each bullet point now has a strength-of-evidence rating consistent with GRADE. … patients taking bisphosphonates found that 89 percent of the cases were associated with treatment of malignancy … Also, we have revised all strength of evidence assessments to reflect GRADE wording. … measure adherence and persistence outside of fracture trials with more formal criteria or scales to grade

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: